Cite
HARVARD Citation
Zylkiewicz, E. et al. (n.d.). SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models. European journal of cancer. pp. S132-. [Online].